These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22766794)

  • 61. Desmoid tumor in patients with familial adenomatous polyposis.
    Leal RF; Silva PV; Ayrizono Mde L; Fagundes JJ; Amstalden EM; Coy CS
    Arq Gastroenterol; 2010; 47(4):373-8. PubMed ID: 21225148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data.
    Timbergen MJM; Colombo C; Renckens M; Kim HS; Rosmalen JV; Salas S; Mullen JT; Colombo P; Nishida Y; Wiemer EAC; Verhoef C; Sleijfer S; Gronchi A; Grünhagen DJ
    Ann Surg; 2021 Jun; 273(6):1094-1101. PubMed ID: 31804402
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.
    Pinto FFE; Mello CAL; Nakagawa SA; Chung WT; Torrezan GT; Barros BDF; Cunha IW; Calsavara VF; Carraro DM; Lopes A
    Clin Orthop Relat Res; 2023 Oct; 481(10):1978-1989. PubMed ID: 37104792
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CTNNB1 mutation-driven hybrid tumor: desmoid fibromatosis with an unusual associated epithelioid component arising in association with a neuromuscular choristoma.
    Zheng X; He X; Lu Y; Chen C; Zhang H
    Virchows Arch; 2024 Apr; 484(4):715-720. PubMed ID: 38183458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study.
    Nieuwenhuis MH; Lefevre JH; Bülow S; Järvinen H; Bertario L; Kernéis S; Parc Y; Vasen HF
    Dis Colon Rectum; 2011 Oct; 54(10):1229-34. PubMed ID: 21904137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aggressive fibromatosis.
    Fisher C; Thway K
    Pathology; 2014 Feb; 46(2):135-40. PubMed ID: 24378386
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.
    Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA
    Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
    Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
    Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential diagnosis and mutation stratification of desmoid-type fibromatosis on MRI using radiomics.
    Timbergen MJM; Starmans MPA; Padmos GA; Grünhagen DJ; van Leenders GJLH; Hanff DF; Verhoef C; Niessen WJ; Sleijfer S; Klein S; Visser JJ
    Eur J Radiol; 2020 Oct; 131():109266. PubMed ID: 32971431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction.
    Saito T; Oda Y; Kawaguchi K; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Lab Invest; 2002 Jan; 82(1):97-103. PubMed ID: 11796830
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].
    Kadmon M; Möslein G; Buhr HJ; Herfarth C
    Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453
    [TBL] [Abstract][Full Text] [Related]  

  • 72. APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
    Stormorken AT; Berg T; Norum OJ; Hølmebakk T; Aaberg K; Steigen SE; Grindedal EM
    Fam Cancer; 2018 Oct; 17(4):539-543. PubMed ID: 29368261
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression.
    Andino L; Cagle PT; Murer B; Lu L; Popper HH; Galateau-Salle F; Sienko AE; Barrios R; Zander DS
    Arch Pathol Lab Med; 2006 Oct; 130(10):1503-9. PubMed ID: 17090192
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
    van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
    BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Breast desmoid tumor management in France: toward a new strategy.
    Duazo-Cassin L; Le Guellec S; Lusque A; Chantalat E; Laé M; Terrier P; Coindre JM; Boulet B; Le Boulc'h M; Gangloff D; Meresse T; Chaput B; Al Ali A; Rimareix F; Bonvalot S; Vaysse C
    Breast Cancer Res Treat; 2019 Jul; 176(2):329-335. PubMed ID: 31016642
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
    Nishida Y; Tsukushi S; Urakawa H; Hamada S; Kozawa E; Ikuta K; Ando Y; Ishiguro N
    Int J Clin Oncol; 2015 Dec; 20(6):1211-7. PubMed ID: 25899770
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Utility of LEF1 to differentiate desmoid fibromatosis from its histologic mimics.
    Jobbagy S; Lozano-Calderon S; Mullen JT; Nielsen GP; Hung YP; Chebib I
    Virchows Arch; 2024 May; 484(5):807-813. PubMed ID: 38503969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis.
    Zhou L; Xu H; Zhou J; Dong L; Zhang P; Yang X; Wang C
    Diagn Pathol; 2019 May; 14(1):34. PubMed ID: 31043173
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Update on desmoid tumors.
    Escobar C; Munker R; Thomas JO; Li BD; Burton GV
    Ann Oncol; 2012 Mar; 23(3):562-569. PubMed ID: 21859899
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.
    Shitoh K; Konishi F; Iijima T; Ohdaira T; Sakai K; Kanazawa K; Miyaki M
    J Clin Pathol; 1999 Sep; 52(9):695-6. PubMed ID: 10655994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.